Rhythm Pharmaceuticals, Inc.RYTMNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank92
5Y CAGR+33.8%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
+33.8%/yr
Long-term compound
Percentile
P92
Near historical high
vs 5Y Ago
4.3x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 27.68% |
| 2024 | -44.02% |
| 2023 | -2.90% |
| 2022 | -5.35% |
| 2021 | -24.52% |
| 2020 | 6.46% |
| 2019 | -86.18% |
| 2018 | -141.94% |
| 2017 | -25.12% |
| 2016 | -145.01% |